Table 4.

Fasting and postprandial C-peptide levels (mg/dL) in placebo- and Fenfuro-treated subjects

				Statistical analyses
Parameters	Treatment	Placebo group (mean±SD)	Treatment group (mean±SD)	Paired t- and p- value	Independent test p- and t-value
Fasting C-peptide levels	Baseline	3.28±2.29	2.60±1.68	t=4.283, p=0.001**	t=0.871, p=0.389, ns
	On completion	4.79±3.09	4.11±2.08	t=4.423, p=0.000**	t=1.140, p=0.260, ns
Postprandial C-peptide levels	Baseline	2.33±1.64	2.56±2.11	t=5.427, p=0.001**	t=1.285, p=0.205, ns
	On completion	4.47±2.53	5.40±2.78	t=7.210, p=0.000**	t=0.438, p=0.663, ns

Data are expressed as mean±SD.

^**Significant reduction; ns, not significant.